Multiomic Health is a next-generation AI-enabled precision medicine venture focusing on metabolic syndrome conditions — cardiovascular disease, diabetes, NAFLD/NASH and obesity. We develop machine learning-enhanced systems biology models and composite biomarkers. Our primary data derives from our own observational clinical studies that deeply profile patients using multiple omics technologies, supplemented by related datasets provided by our partners. Generated models and novel biomarkers are then used to originate new therapeutic and diagnostic R&D programmes for subsequent co-development and global commercialization with multinational biopharma and diagnostic companies.